| MeSH term | MeSH ID | Detail |
|---|---|---|
| AIDS-Related Opportunistic Infections | D017088 | 9 associated lipids |
| Skin Diseases, Bacterial | D017192 | 8 associated lipids |
| Pityriasis Rosea | D017515 | 3 associated lipids |
| Aortic Aneurysm, Abdominal | D017544 | 5 associated lipids |
| Pelvic Pain | D017699 | 7 associated lipids |
| Community-Acquired Infections | D017714 | 8 associated lipids |
| Granuloma, Pyogenic | D017789 | 2 associated lipids |
| Furcation Defects | D017823 | 1 associated lipids |
| T-Lymphocytopenia, Idiopathic CD4-Positive | D018344 | 1 associated lipids |
| Pneumonia, Bacterial | D018410 | 16 associated lipids |
Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Bingen E et al. | Activity of telithromycin against penicillin-resistant Streptococcus pneumoniae isolates recovered from French children with invasive and noninvasive infections. | 2003 | Antimicrob. Agents Chemother. | pmid:12821495 |
| Roblin PM et al. | In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae. | 2003 | Antimicrob. Agents Chemother. | pmid:12604555 |
| Schiedler V et al. | Pattern of antibiotic use in a trachoma-endemic region of Nepal: implications for mass azithromycin distribution. | 2003 | Ophthalmic Epidemiol | pmid:12607157 |
| Mesa FL et al. | Antibiotic treatment of incipient drug-induced gingival overgrowth in adult renal transplant patients. | 2003 | J. Periodont. Res. | pmid:12608908 |
| [Uncomplicated community-acquired pneumonia. Under control in 3 treatment days]. | 2003 | MMW Fortschr Med | pmid:12619240 | |
| Song Z and Wang C | Ultrasensitive assay of azithromycin in medicine and bio-fluids based on its enhanced luminol-H(2)O(2) chemiluminescence reaction using flow injection technique. | 2003 | Bioorg. Med. Chem. | pmid:14642581 |
| Mecaskey JW et al. | The possibility of eliminating blinding trachoma. | 2003 | Lancet Infect Dis | pmid:14592604 |
| Arreaza L et al. | Emergence of gonococcal strains with resistance to azithromycin in Spain. | 2003 | J. Antimicrob. Chemother. | pmid:12493814 |
| Lobzin IuV et al. | [New achievements in the diagnosis and treatment of disseminated urogenital chlamydiosis]. | 2003 | Vestn. Akad. Med. Nauk SSSR | pmid:14598508 |
| Adachi JA et al. | Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. | 2003 | Clin. Infect. Dis. | pmid:14557959 |
| Schriever C et al. | Red wine, resveratrol, Chlamydia pneumoniae and the French connection. | 2003 | Atherosclerosis | pmid:14644410 |
| Jennings MB et al. | Comparison of azithromycin and cefadroxil for the treatment of uncomplicated skin and skin structure infections. | 2003 | Cutis | pmid:14533837 |
| Callaghan R and Allen M | Mycobacterium malmoense infection of the knee. | 2003 | Ann. Rheum. Dis. | pmid:14583565 |
| Laming AC and Currie BJ | An evaluation of a SAFE-style trachoma control program in central Australia. | 2003 | Med. J. Aust. | pmid:12921100 |
| Feldman RB et al. | Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital. | 2003 | Arch. Intern. Med. | pmid:12885688 |
| Dunne MW et al. | Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media. | 2003 | J. Antimicrob. Chemother. | pmid:12888586 |
| Rush C and Simon MW | The effect of amoxicillin-clavulanate, cefixime and azithromycin on normal throat flora in children with group A streptococcal pharyngitis. | 2003 | Clin Pediatr (Phila) | pmid:12862350 |
| Lildholdt T et al. | The natural history of recurrent acute tonsillitis and a clinical trial of azithromycin for antibiotic prophylaxis. | 2003 | Clin Otolaryngol Allied Sci | pmid:12871256 |
| Farley TA et al. | The acceptability and behavioral effects of antibiotic prophylaxis for syphilis prevention. | 2003 | Sex Transm Dis | pmid:14603093 |
| Sugihara E et al. | Macrolide antibiotics directly reduce active oxygen generation by neutrophils in human peripheral blood. | 2003 | Kurume Med J | pmid:12971257 |
| Taylor WR et al. | Tolerability of azithromycin as malaria prophylaxis in adults in northeast papua, indonesia. | 2003 | Antimicrob. Agents Chemother. | pmid:12821468 |
| Seral C et al. | Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages. | 2003 | Antimicrob. Agents Chemother. | pmid:12821480 |
| Katusic D et al. | Azithromycin vs doxycycline in the treatment of inclusion conjunctivitis. | 2003 | Am. J. Ophthalmol. | pmid:12654359 |
| Carryn S et al. | Activity of beta-lactams (ampicillin, meropenem), gentamicin, azithromycin and moxifloxacin against intracellular Listeria monocytogenes in a 24 h THP-1 human macrophage model. | 2003 | J. Antimicrob. Chemother. | pmid:12654747 |
| Danesi R et al. | Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg. | 2003 | J. Antimicrob. Chemother. | pmid:12654753 |
| Zhanel GG et al. | Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations. | 2003 | J. Antimicrob. Chemother. | pmid:12775677 |
| Blandford JM and Gift TL | The cost-effectiveness of single-dose azithromycin for treatment of incubating syphilis. | 2003 | Sex Transm Dis | pmid:12782951 |
| Purkins L et al. | No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers. | 2003 | Br J Clin Pharmacol | pmid:14616411 |
| Guchev IA et al. | [Effect of chemoprophylaxis on pneumonia incidence in organized groups]. | 2003 | Voen Med Zh | pmid:12722514 |
| Maekawa M et al. | [Alteration of antibacterial activity of tosufloxacin and various antibacterial agents against Streptococcus pneumoniae]. | 2003 | Jpn J Antibiot | pmid:12723396 |
| Johnson SR et al. | Mutations causing in vitro resistance to azithromycin in Neisseria gonorrhoeae. | 2003 | Int. J. Antimicrob. Agents | pmid:12727073 |
| Skerk V et al. | Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. | 2003 | Int. J. Antimicrob. Agents | pmid:12727080 |
| Trad O et al. | Eradication of Cryptosporidium in four children with acute lymphoblastic leukemia. | 2003 | J. Trop. Pediatr. | pmid:12729299 |
| Zhou WQ et al. | [Clinic efficacy of treating chronic prostatitis caused by Neisseria gonorrhoeae with azithromycin aspartic-acid injection]. | 2003 | Zhonghua Nan Ke Xue | pmid:12680331 |
| Ioannidis J and Wilkinson D | HIV: prevention of opportunistic infections. | 2003 | Clin Evid | pmid:15555123 |
| Ito K et al. | Prediction of the in vivo interaction between midazolam and macrolides based on in vitro studies using human liver microsomes. | 2003 | Drug Metab. Dispos. | pmid:12814973 |
| Schilling F | [Chronic recurrent multifocal osteomyelitis. Opinion exchange concerning the article by T. Seidl et al in Der Orthopäde (2003) 32:535-540]. | 2003 | Orthopade | pmid:14655012 |
| Lin L et al. | A retrospective study on clinical features of and treatment methods for 77 severe cases of SARS. | 2003 | Am. J. Chin. Med. | pmid:14992536 |
| Aznabaev MT et al. | [Use of cycloferon in a combined treatment of chlamydial conjunctivitis]. | 2003 Jan-Feb | Vestn Oftalmol | pmid:12608044 |
| Scheinfeld NS et al. | Macrolides in dermatology. | 2003 Jan-Feb | Clin. Dermatol. | pmid:12609587 |
| Bevan CD et al. | Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease. | 2003 Jan-Feb | J. Int. Med. Res. | pmid:12635534 |
| Prata A et al. | Efficacy of azithromycin in the treatment of cutaneous leishmaniasis. | 2003 Jan-Feb | Rev. Soc. Bras. Med. Trop. | pmid:12715065 |
| Knuf M et al. | [Lymphadenitis colli due to non-tuberculous mycobacteria (NTM): a case-series and review of the literature]. | 2003 Jan-Feb | Klin Padiatr | pmid:12545419 |
| Bernstein JM | The farmer and the tractor. | 2003 Mar-Apr | Skinmed | pmid:14673307 |
| Aktan B et al. | Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion. | 2003 Nov-Dec | Pol J Pharmacol | pmid:14730107 |
| Khandekarf R and Mohammed AJ | Outcome of azithromycin treatment of active trachoma in Omani school children. | 2003 Sep-Nov | East. Mediterr. Health J. | pmid:16450533 |
| Wyrick PB and Knight ST | Pre-exposure of infected human endometrial epithelial cells to penicillin in vitro renders Chlamydia trachomatis refractory to azithromycin. | 2004 | J. Antimicrob. Chemother. | pmid:15163653 |
| Frenck RW et al. | Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents. | 2004 | Clin. Infect. Dis. | pmid:15034826 |
| Smelov V et al. | Azithromycin treatment follow-up: antibacterial susceptibility of Chlamydia trachomatis in patients with chronic prostatitis. | 2004 | Int. J. Antimicrob. Agents | pmid:15037332 |
| Manavi K et al. | The prevalence of rectal chlamydial infection amongst men who have sex with men attending the genitourinary medicine clinic in Edinburgh. | 2004 | Int J STD AIDS | pmid:15038860 |
| Hartmann M | [Therapy of syphilis]. | 2004 | Hautarzt | pmid:14968333 |
| Law C and Amsden GW | Single-dose azithromycin for respiratory tract infections. | 2004 | Ann Pharmacother | pmid:14970367 |
| Kanazawa S et al. | Azithromycin and bronchiolitis obliterans. | 2004 | Am. J. Respir. Crit. Care Med. | pmid:14982826 |
| Ranque S et al. | In vitro activity of azithromycin and dirithromycin against axenic Entamoeba histolytica. | 2004 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:15599659 |
| Ngan CC et al. | Susceptibility testing of Singapore strains of Mycoplasma hominis to tetracycline, gatifloxacin, moxifloxacin, ciprofloxacin, clindamycin, and azithromycin by the Etest method. | 2004 | Diagn. Microbiol. Infect. Dis. | pmid:15023431 |
| Máiz Carro L and Cantón Moreno R | [Azithromycin therapy in cystic fibrosis]. | 2004 | Med Clin (Barc) | pmid:15030744 |
| Baumann U et al. | Long term azithromycin therapy in cystic fibrosis patients: a study on drug levels and sputum properties. | 2004 | Can. Respir. J. | pmid:15045047 |
| Ables AZ and Warren PK | High-dose azithromycin or amoxicillin-clavulanate for recurrent otitis media? | 2004 | J Fam Pract | pmid:15000920 |
| Cafini F et al. | Bactericidal activity of moxifloxacin against multidrug-resistant Streptoccocus pneumoniae at clinically achievable serum and epithelial lining fluid concentrations compared with three other antimicrobials. | 2004 | Int. J. Antimicrob. Agents | pmid:15380257 |
| Erdeve O et al. | The probiotic effect of Saccharomyces boulardii in a pediatric age group. | 2004 | J. Trop. Pediatr. | pmid:15357564 |
| Tsai WC et al. | Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection. | 2004 | Am. J. Respir. Crit. Care Med. | pmid:15361366 |
| Skerk V et al. | Azithromycin: 4.5- or 6.0-gram dose in the treatment of patients with chronic prostatitis caused by Chlamydia trachomatis--a randomized study. | 2004 | J Chemother | pmid:15332719 |
| AltintaÅŸ E et al. | Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy. | 2004 | Turk J Gastroenterol | pmid:15334317 |
| Koeth LM et al. | Streptococcus pneumoniae in vitro development of resistance to amoxicillin/clavulanic acid, cefaclor, levofloxacin and azithromycin. | 2004 | Int. J. Antimicrob. Agents | pmid:15288313 |
| Rahav G et al. | Azithromycin versus comparative therapy for the treatment of community acquired pneumonia. | 2004 | Int. J. Antimicrob. Agents | pmid:15288319 |
| Brian SR and Kimbrough RC | Salvage of a prosthetic knee joint infected with resistant pneumococcus. A case report. | 2004 | J Bone Joint Surg Am | pmid:15466745 |
| Nariai A et al. | [Efficacy of azithromycin as the empiric therapy in children with community-acquired pneumonia who were isolated macrolide resistant Streptococcus pneumoniae from nasopharynx]. | 2004 | Kansenshogaku Zasshi | pmid:15287476 |
| Lukehart SA et al. | Macrolide resistance in Treponema pallidum in the United States and Ireland. | 2004 | N. Engl. J. Med. | pmid:15247355 |
| Antibiotics ineffective for prevention of recurrent MI. | 2004 | J Fam Pract | pmid:15251088 | |
| Mizunoe S et al. | Clarithromycin and azithromycin induce apoptosis of activated lymphocytes via down-regulation of Bcl-xL. | 2004 | Int. Immunopharmacol. | pmid:15251115 |
| Bouwman JJ et al. | Azithromycin inhibits interleukin-6 but not fibrinogen production in hepatocytes infected with cytomegalovirus and chlamydia pneumoniae. | 2004 | J. Lab. Clin. Med. | pmid:15252403 |
| Tindberg Y et al. | Helicobacter pylori eradication in children and adolescents by a once daily 6-day treatment with or without a proton pump inhibitor in a double-blind randomized trial. | 2004 | Aliment. Pharmacol. Ther. | pmid:15274666 |
| Halpern MT and Cifaldi MA | Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia? | 2004 | Clin. Infect. Dis. | pmid:15206068 |
| Carr RR and Nahata MC | Azithromycin for improving pulmonary function in cystic fibrosis. | 2004 | Ann Pharmacother | pmid:15213312 |
| Clyti E et al. | [Short treatment of donovanosis with azithromycin]. | 2004 | Ann Dermatol Venereol | pmid:15235534 |
| Snider LA and Swedo SE | PANDAS: current status and directions for research. | 2004 | Mol. Psychiatry | pmid:15241433 |
| Ruuskanen O | Safety and tolerability of azithromycin in pediatric infectious diseases: 2003 update. | 2004 | Pediatr. Infect. Dis. J. | pmid:14770077 |
| Klein JO and Schaad UB | [Use of azithromycin in the treatment of acute otitis media and tonsillopharyngitis: summary and conclusions. | 2004 | Pediatr. Infect. Dis. J. | pmid:14770078 |
| Asakura E et al. | Azithromycin reverses anticancer drug resistance and modifies hepatobiliary excretion of doxorubicin in rats. | 2004 | Eur. J. Pharmacol. | pmid:14744620 |
| Gonzalez BE et al. | Azithromycin compared with beta-lactam antibiotic treatment failures in pneumococcal infections of children. | 2004 | Pediatr. Infect. Dis. J. | pmid:15131461 |
| Parry CM | The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam. | 2004 | Trans. R. Soc. Trop. Med. Hyg. | pmid:15138078 |
| Paik JW et al. | Inhibition of cyclosporin A-induced gingival overgrowth by azithromycin through phagocytosis: an in vivo and in vitro study. | 2004 | J. Periodontol. | pmid:15088875 |
| Guchev IA et al. | Two regimens of azithromycin prophylaxis against community-acquired respiratory and skin/soft-tissue infections among military trainees. | 2004 | Clin. Infect. Dis. | pmid:15095213 |
| Miron D et al. | Azithromycin as an alternative to nalidixic acid in the therapy of childhood shigellosis. | 2004 | Pediatr. Infect. Dis. J. | pmid:15071299 |
| Palcevski G et al. | Antibiotic use profile at paediatric clinics in two transitional countries. | 2004 | Pharmacoepidemiol Drug Saf | pmid:15072118 |
| Gross M et al. | Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor. | 2004 | J. Antimicrob. Chemother. | pmid:14963065 |
| Gandhi R et al. | Pharmacokinetic evaluation of an azithromycin controlled release dosage form in healthy human volunteers: a single dose study. | 2004 | Int J Pharm | pmid:14726116 |
| Pino Rivero V et al. | [Facial palsy caused by otitis media with effusion in a 9-year old child]. | 2004 | An Otorrinolaringol Ibero Am | pmid:15663088 |
| Fernandez-Obregon A | Oral use of azithromycin for the treatment of acne rosacea. | 2004 | Arch Dermatol | pmid:15096385 |
| Dias R and Caniça M | Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14. | 2004 | J. Antimicrob. Chemother. | pmid:15531597 |
| Tobin JM et al. | Which treatment for genital tract Chlamydia trachomatis infection? | 2004 | Int J STD AIDS | pmid:15537459 |
| Iur'ev SIu et al. | [Azithromycin levels in the chorion tissue within the first three months of the pregnancy term]. | 2004 | Antibiot. Khimioter. | pmid:15850052 |
| Brandén E et al. | Intermittent azithromycin treatment for respiratory symptoms in patients with chronic Chlamydia pneumoniae infection. | 2004 | Scand. J. Infect. Dis. | pmid:15764166 |
| Carter G et al. | A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation. | 2004 | Antimicrob. Agents Chemother. | pmid:15561879 |
| Soni N et al. | Recurrent acute interstitial nephritis induced by azithromycin. | 2004 | Pediatr. Infect. Dis. J. | pmid:15602202 |
| Zervos M et al. | Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia. | 2004 | Treat Respir Med | pmid:15606222 |
| Jones S et al. | The tip of the iceberg: opportunistic screening for Chlamydia trachomatis in asymptomatic patients attending a young people's health clinic reveals a high prevalence--a pilot study. | 2004 | Sex Health | pmid:16334993 |
| Gregory AR et al. | Ophthalmomyiasis caused by the sheep bot fly Oestrus ovis in northern Iraq. | 2004 | Optom Vis Sci | pmid:15300116 |
| McHugh RC et al. | A topical azithromycin preparation for the treatment of acne vulgaris and rosacea. | 2004 | J Dermatolog Treat | pmid:15370397 |
| Gattringer R et al. | Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary. | 2004 | Int. J. Antimicrob. Agents | pmid:15325435 |